Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12% in a year to 1,172 drug-related deaths ...

The Thistle drug consumption room - the first of its kind in the UK - will open in Glasgow on Monday in a bid to drive down ...

Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...

New Mountain Capital, LLC ("New Mountain"), a leading growth-oriented investment firm with more than $55 billion in assets under management, today announced a definitive agreement to acquire Machinify ...

Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

Analyzing the WHO Global Tuberculosis Report 2024: Key Insights from Global and Chinese DataA new article published in the journal zoonoses, decodes ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...